Abramson Cancer Center of the U of P Core Support Grant

艾布拉姆森癌症中心促进跨学科的癌症研究，教育和病人护理。其 299名成员来自大学的41个部门和8个学院，拥有120，755，622美元 研究和培训（年度直接费用）达200万美元，在过去五年中增加了73%，其中 111，281，669美元是同行评审的，56，709，782美元是NCI资助的（过去五年增加了138%）。这 包括20个NIH P01和7个P50。John Glick博士自1985年以来一直担任董事。十一 研究计划包括癌症中心的三个部门（基础研究，临床 癌症控制和人口科学）。癌症中心支持15个共享资源， 其中五个是新的。强大的研究计划和领先的共享资源的发展， 在优先领域招聘优秀教师，并获得额外的研究空间 使癌症中心得以实现其使命。一个持续的战略规划进程确定了 今后的方向，同时指导目前的活动和资源分配。各种各样的研讨会和 务虚会以及跨学科的实验室空间是癌症中心 成功地促进了互动和协作。发展基金对教师招聘至关重要 以及为创新试点项目提供资金，这些项目有可能获得同行评审资金， 研究计划和共享资源。癌症控制和人口科学司 受益于Caryn Lerman博士作为副主任和其他重要教师的招聘 招募临床研究部的进展是由创新的转化研究区分 在所有的研究项目和国家认可的实验治疗的努力。在基础科学中， 领导层的变化导致了翻译研究活动的增加和合作的增加。的 癌症中心继续符合综合指南，并于1999年获得最后批准。

The Abramson Cancer Center facilitates interdisciplinary cancer research, education, and patient care. Its 299 members are drawn from 41 Departments and eight Schools of the University and have $120,755,622 million in research and training (annual direct costs), a 73% increase in the past five years, of which $111,281,669 is peer-reviewed and $56,709,782 is NCI funded (138% increase in the past five years). This includes 20 NIH P01s and seven P50s. John Glick, MD, has served as Director since 1985. Eleven Research Programs comprise the Cancer Center's three Divisions (Fundamental Research, Clinical Research, Cancer Control and Population Sciences). The Cancer Center supports 15 Shared Resources, five of which are new. The development of strong Research Programs and leading-edge Shared Resources, the recruitment of outstanding faculty in areas of priority, and the acquisition of additional research space have enabled the Cancer Center to realize its mission. An ongoing strategic planning process identifies future directions, while guiding current activities and resource allocations. A wide range of seminars and retreats as well as interdisciplinary laboratory space are among the ways in which the Cancer Center sucessfully facilitates interaction and collaboration. Developmental Funds are critical to faculty recruitment and the funding of innovative pilot projects with the potential for peer-reviewed funding, translational research initiatives, and Shared Resources. The Division of Cancer Control and Population Sciences has benefited from the recruitment of Caryn Lerman, PhD, as Associate Director and other significant faculty recruitments. The Clinical Research Division's progress is distinguished by innovative translational research in all Research Programs and a nationally recognized experimental therapeutics effort. In the basic sciences, leadership changes have led to greater activity in translational research and increased collaborations. The Cancer Center continues to meet Comprehensiveness guidelines, and was last approved in 1999.